17 results
PRE 14A
APRE
Aprea Therapeutics Inc
27 May 22
Preliminary proxy
5:00pm
and biotechnology industry experience, as well as broad corporate finance expertise from his tenure in investment banking. Prior to joining Aprea, from 2014 … career. During his tenure at Johnson & Johnson, Mr. Grissinger held positions of Vice President and Head, Worldwide Pharmaceutical Licensing as well
8-K
fz9ia9n
16 May 22
Entry into a Material Definitive Agreement
9:28pm
10-K/A
bxiorm62 sdbkj
2 May 22
Annual report (amended)
5:15pm
8-K
EX-99.1
ih19e7
29 Jun 20
Aprea Therapeutics Appoints Fouad Namouni, M.D. and Richard Peters, M.D., Ph.D. to Board of Directors
12:00am
DEF 14A
nm87ubc
29 Apr 20
Definitive proxy
4:30pm
424B4
u735wmrm1 cb10zbw
4 Oct 19
Prospectus supplement with pricing info
12:00am
S-1/A
mdtf1e11wpbzivbh0
23 Sep 19
IPO registration (amended)
6:48am
S-1
1ty72e6r8 1ix9o
6 Sep 19
IPO registration
5:22pm
DRS/A
pwg5a
20 Aug 19
Draft registration statement (amended)
12:00am
DRS
tw5gsv2 zsg7
12 Jul 19
Draft registration statement
12:00am
- Prev
- 1
- Next